| Richard G King, MD | |
|
200 Clinic Dr, Madisonville, KY 42431-1661 | |
| (270) 825-7200 | |
| Not Available |
| Full Name | Richard G King |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 200 Clinic Dr, Madisonville, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124124128 | NPI | - | NPPES |
| 000000044259 | Other | BCBS PROVIDER NUMBER | |
| 64226467 | Medicaid | KY | |
| 22646 | Other | KY | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 22646 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard G King, MD 200 Clinic Dr, Madisonville, KY 42431-1661 Ph: (270) 825-7200 | Richard G King, MD 200 Clinic Dr, Madisonville, KY 42431-1661 Ph: (270) 825-7200 |
News Archive
AMAG Pharmaceuticals, Inc. today announced the completion of patient enrollment in the second of the company's two phase III studies that comprise its global registrational program for Feraheme (ferumoxytol) in patients with iron-deficiency anemia (IDA) who are not candidates for oral iron, regardless of the underlying cause.
The Los Angeles Philharmonic Association, the USC Brain and Creativity Institute and Heart of Los Angeles (HOLA) are delighted to announce a longitudinal research collaboration to investigate the emotional, social and cognitive effects of musical training on childhood brain development.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
"PET/CT is very helpful in determining where we should pinpoint our biopsies for recurrent disease," said Dr. Carol Shores, assistant professor of otolaryngology/head and neck surgery at UNC and the report's senior author. Shores is a member of the UNC Lineberger Comprehensive Cancer Center.
As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters <232> Elemental Impurities-Limits and <233> Elemental Impurities-Procedures. The new standards provide procedures for the detection of selected impurities in drug products based on modern analytical methods, as well as acceptable limits for their presence based on toxicity data and exposure levels.
› Verified 4 days ago
Kristin Wickham, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 | |
Robert G. Holzknecht, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 S Main St, Madisonville, KY 42431 Phone: 270-821-4444 Fax: 270-821-9188 | |
Catherine S Montz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 | |
Michael Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 230 Madison Square Dr Ste C, Madisonville, KY 42431 Phone: 270-821-6262 | |
Robert Lamont Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 | |
Marium Iqbal, Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 |